title: Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice.
authors.forename: J
authors.initials: J
authors.lastname: Gołab
authors.forename: R
authors.initials: R
authors.lastname: Zagozdzon
authors.forename: T
authors.initials: T
authors.lastname: Stokłosa
authors.forename: M
authors.initials: M
authors.lastname: Jakóbisiak
authors.forename: Z
authors.initials: Z
authors.lastname: Pojda
authors.forename: E
authors.initials: E
authors.lastname: Machaj
mesh_terms: D000740:Anemia / Q000139:chemically induced* / Q000517:prevention & control*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004347:Drug Interactions; D004921:Erythropoietin / Q000494:pharmacology*; D006454:Hemoglobins / Q000032:analysis; D018664:Interleukin-12 / Q000494:pharmacology*; D051379:Mice; D010976:Platelet Count / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D006454:Hemoglobins; D004921:Erythropoietin; D018664:Interleukin-12